Y-mAbs Therapeutics
YMAB
#8110
Rank
ยฃ0.16 B
Marketcap
ยฃ3.61
Share price
-1.27%
Change (1 day)
-70.82%
Change (1 year)

Operating Margin for Y-mAbs Therapeutics (YMAB)

Operating Margin as of March 2025 (TTM): -33.99%

According to Y-mAbs Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -33.99%. At the end of 2024 the company had an Operating Margin of -34.00%.

Operating Margin history for Y-mAbs Therapeutics from 2021 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-34.00%38.2%
2023-24.60%-83.2%
2022-146.43%-7.56%
2021-158.39%-72.46%
2020-575.12%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.